In 2019 a Japanese group identified four patients with neurodevelopmental disorders presenting de novo variants in CSNK2A1, but also in CSNK2B genes.247 All patients showed intellectual disabilities and developmental delays. Here, CSNK2A1 is linked to neurodevelopmental disorder.